Cancer Therapy By Targeting Hypoxia-Inducible Factor-1
Journal:
Current Cancer Drug Targets
Volume:
10
Page:
782-796
Author(s):
Y. Li and D. Ye
Interleukin 2 in Cancer Therapy
Journal:
Current Medicinal Chemistry
Volume:
17
Page:
3297-3302
Author(s):
G. K. Antony and A. Z. Dudek
Recent Advances in Structural Studies of the Carbonic Anhydrase Family: The Crystal Structure of Human CA IX and CA XIII
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3246-3254
Author(s):
Claudiu T. Supuran, Anna Di Fiore, Vincenzo Alterio, Simona Maria Monti and Giuseppina De Simone
Carbonic Anhydrase IX as an Anticancer Therapy Target: Preclinical Evaluation of Internalizing Monoclonal Antibody Directed to Catalytic Domain
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
3255-3263
Author(s):
M. Zatovicova, L. Jelenska, A. Hulikova, L. Csaderova, Z. Ditte, P. Ditte, T. Goliasova, J. Pastorek and S. Pastorekova
Highly Selective MEK Inhibitors
Journal:
Current Enzyme Inhibition
Volume:
6
Page:
146-157
Author(s):
Chih-Shia Lee and Nicholas S. Duesbery
HDL Stimulates apoM Secretion
Journal:
Protein & Peptide Letters
Volume:
17
Page:
1285-1289
Author(s):
Josefin Ahnstrom, Olof Axler and Bjorn Dahlback
Tyrosine Kinase Receptor Transactivation Associated to G Protein-Coupled Receptors
Journal:
Current Drug Targets
Volume:
11
Page:
1169-1180
Author(s):
Vanessa Almendro, Susana Garcia-Recio and Pedro Gascon
Prevention and Treatment of Bone Metastases
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
2998-3006
Author(s):
E. J. Woodward and R. E. Coleman
Therapeutic Approach of Primary Bone Tumours by Bisphosphonates
Journal:
Current Pharmaceutical Design
Volume:
16
Page:
2981-2987
Author(s):
G. Moriceau, B. Ory, B. Gobin, F. Verrecchia, F. Gouin, F. Blanchard, F. Redini and D. Heymann
Hypoxia-Inducible Factor 1 in Tumor Radioresistance
Journal:
Current Signal Transduction Therapy
Volume:
5
Page:
188-196
Author(s):
Hiroshi Harada and Masahiro Hiraoka